News
-
-
PRESS RELEASE
Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient’s CDK7 Inhibitors
Lonza announces exclusive access to Qurient's CDK7 inhibitors for dual-payload ADC technology, enhancing its position in the growing market. The agreement strengthens Lonza's ADC toolbox with new SYN-duo® CC format -
-
-
-
-
-
PRESS RELEASE
Lonza Further Strengthens US Manufacturing Presence with Addition of a Commercial Spray-Drying Facility in Bend, Oregon
Lonza strengthens US manufacturing presence with new commercial spray-drying facility in Bend, Oregon, enhancing particle engineering and bioavailability capabilities -
-